Figure 1

Changes in plasma viral RNA during antiretroviral therapy between the HIV/HCV co-infection and the HIV or HCV mono-infection group. Each symbol represents the log₁₀ HIV-1 or HCV RNA copies per milliliter of plasma. HIV-1 and HCV RNA levels were measured at six time points: before the start of therapy (baseline) and at 4, 12, 24, 36 and 48 weeks of antiretroviral therapy. (A) Changes in plasma HIV-1 RNA during HAART between the HIV/HCV co-infection (dotted line) and the HIV mono-infection group (solid line). (B) Changes in plasma HCV RNA during HCV-ART between the HIV/HCV co-infection (dotted line) and the HCV mono-infection group (solid line).